
Kindstar Globalgene Proposed Listing on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Jun 28, 2021 – (ACN Newswire via SEAPRWire.com) – A leading player in China’s independent esoteric clinical testing service provider – Kindstar Globalgene Technology, Inc. (“Kindstar Globalgene” or the “Company”, together with its subsidiaries, the “Group”, stock code: 9960.HK), today announced the proposed listing of its shares on the Main Board of The... » read more